903564-48-7
- Product Name
- 903564-48-7
- CAS No.
- 903564-48-7
- Chemical Name
- 903564-48-7
- Synonyms
- UM-164;CS-2793;DAS-DFGO-II;UM164;UM-164;UM 164;UM-164 (DAS-DFGO-II);p38 MAPK,Autophagy,UM-164,Src,UM 164,inhibit,Inhibitor;2-((6-(4-(2-Hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)thiazole-5-carboxamide;5-Thiazolecarboxamide, 2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-N-[2-methyl-5-[[3-(trifluoromethyl)benzoyl]amino]phenyl]-
- CBNumber
- CB54033656
- Molecular Formula
- C30H31F3N8O3S
- Formula Weight
- 640.68
- MOL File
- 903564-48-7.mol
903564-48-7 Property
- Density
- 1.433±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO: 5 mg/ml
- form
- A crystalline solid
- pka
- 11.40±0.70(Predicted)
- color
- White to off-white
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H315Causes skin irritation
H319Causes serious eye irritation
- Precautionary statements
-
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P321Specific treatment (see … on this label).
P332+P313IF SKIN irritation occurs: Get medical advice/attention.
P337+P313IF eye irritation persists: Get medical advice/attention.
N-Bromosuccinimide Price
- Product number
- 26188
- Product name
- UM-164
- Packaging
- 1mg
- Price
- $44
- Updated
- 2024/03/01
- Product number
- 26188
- Product name
- UM-164
- Packaging
- 5mg
- Price
- $140
- Updated
- 2024/03/01
- Product number
- 26188
- Product name
- UM-164
- Packaging
- 10mg
- Price
- $257
- Updated
- 2024/03/01
- Product number
- 26188
- Product name
- UM-164
- Packaging
- 25mg
- Price
- $533
- Updated
- 2024/03/01
- Product number
- CS-0043628
- Product name
- UM-164
- Purity
- 99.08%
- Packaging
- 5mg
- Price
- $110
- Updated
- 2021/12/16
903564-48-7 Chemical Properties,Usage,Production
Biological Activity
UM-164 (DAS-DFGO-II) is a potent c-Src inhibitor with Kd of 2.7 nM. It also highly inhibits p38α and p38β activity.
in vitro
In biochemical assays, UM-164 is a highly potent inhibitor of c-Src with a binding constant comparable with Dasatinib (UM-164 K d =2.7 nM, Dasatinib K d =0.7 nM). To confirm that UM-164 is capable of inhibiting the activation of c-Src in vitro, the effect of UM-164 is examined on the c-Src autophosphorylation in two TNBC cell lines ( MDA-MB 231 and SUM 149). Inhibition of c-Src autophosphorylation is detected in a concentration- and a time-dependent manner. At 120 minutes, complete abrogation of c-Src autophosphorylation is observed at 50 nM, demonstrating that UM-164 is a potent c-Src inhibitor in vitro. Flow cytometry experiments demonstrate that UM-164 treatment of MDA-MB 231 and SUM 149 increased the proportion of G 0 -G 1 cells by 25% and 28%, respectively, and concurrently decreased the fraction of S cells by 16% and 19%, respectively.
in vivo
A xenograft study is performed using NCr/nude mice implanted with MDA-MB 231 and SUM 149 cell lines. Once the tumors become palpable, the mice are randomized into control and treatment groups. Mice are injected intraperitoneally with either drug (10 and 20 mg/kg in both xenograft studies; a 15 mg/kg dose is added to the SUM 149 xenograft studies) or vehicle every other day (n=5 for each group). At the selected doses of UM-164 , there is no significant weight loss or gross abnormalities observed in the treated animals, even after 52 days of treatment. However, tumor growth is significantly inhibited in both the 10 mg/kg and 20 mg/kg dose groups compared with the vehicle-treated group (P<0.026 and P<0.004, respectively).
target
| p38α
| p38β
| c-Src 2.7 nM (Kd) |
903564-48-7 Preparation Products And Raw materials
Raw materials
Preparation Products
903564-48-7 Suppliers
- Tel
- 15385513552
- 2904539281@qq.com
- Country
- China
- ProdList
- 289
- Advantage
- 60
- Tel
- 021-52996696，15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4512
- Advantage
- 55
- Tel
- 021-61350663 13052117465
- Fax
- 021-61350662
- sales@zehanbiopharma.com
- Country
- China
- ProdList
- 1009
- Advantage
- 55
- Tel
- 13656237714 13656237714
- Fax
- 0512-65852853
- xiaokunfu@kyyykj.com
- Country
- China
- ProdList
- 293
- Advantage
- 55
- Tel
- 021-58088081 Q3252066219
- Fax
- QQ3382968513
- danping@shsendpharm.com
- Country
- China
- ProdList
- 3130
- Advantage
- 55
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8011
- Advantage
- 62
- Tel
- 21-31433387 15618786686
- Fax
- QQ:1369748377
- sales@rechemscience.com
- Country
- China
- ProdList
- 2992
- Advantage
- 58
- Tel
- 010-60605840 18892239720
- Fax
- 010-60605840
- psaitong@jm-bio.com
- Country
- China
- ProdList
- 12306
- Advantage
- 58
- Tel
- 15901858719
- Fax
- qq2126935757
- 2126935757@qq.com
- Country
- China
- ProdList
- 311
- Advantage
- 55
- Tel
- 021-58180488
- Fax
- 021-58180499
- sales@Medchemleader.com
- Country
- China
- ProdList
- 1005
- Advantage
- 58